New bradykinin Analogues Substituted in Positions 6 and 7 with Enantiomers of N-Methylphenylalanine

• Autorzy: Wierzba T. , Derdowska I. , Juzwa W. , Neubert K. , Hartrodt B. , Lammek B.
• Języki publikacji: EN

Abstrakty

EN

Four new analogues of a previously designed bradykinin antagonist, D-Arg-Arg-Pro- -Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg, containing replacements in positions 6 and 7 with all possible combinations of enantiomers of N-methylphenylalanine (MePhe) were designed, synthesized and bioassayed. The presence of two consecutive MePhe residues in the sequence of the analogues caused great difficulties in the synthesis. The best results for the CO-N(CH3) bond formation were obtained using O-(7-azabenzotriazol-1-yl)-1,1,3,3- -tetramethyluronium hexafluorophosphate/7-azabenzotriazol-1-ol (HATU/HOAt) as coupling reagent (Fmoc strategy). The antagonistic potency of these peptides was assessed by their ability to inhibit vasodepressor response to exogenous bradykinin in conscious rats. Our results showed that the modifications proposed resulted in a decrease in antagonistic activity. However, we demonstrated once again that the D-amino acid in position 7 ofBKantagonists may be replaced by a suitable L-amino acid residue. Our results may be of value in the design of new B2-antagonists.

Słowa kluczowe

EN

bradykinin; N-methylphenylalanine substitution; B2-antagonists

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2002
• Tom: Vol. 76 / nr 5
• Strony: 713--719

Twórcy

autor

Wierzba T.

• 'Department of Physiology, Medical Academy of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland

autor

Derdowska I.

• Faculty of Chemistry, University of Gdańsk, Sobieskiego 18, 80-952 Gdańsk, Poland

autor

Juzwa W.

• 'Department of Physiology, Medical Academy of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland

autor

Neubert K.

• Institute of Biochemistry, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Strafie 3, 06120 Halle (Saale), Germany

autor

Hartrodt B.

• Institute of Biochemistry, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Strafie 3, 06120 Halle (Saale), Germany

autor

Lammek B.

• Faculty of Chemistry, University of Gdańsk, Sobieskiego 18, 80-952 Gdańsk, Poland

• Bibliogr. 15 poz., rys.

Bibliografia

• 1. Griesbacher T. and Lembeck F., Br. J. Pharmacol., 92, 333 (1987).
• 2. Farmer S.G. and Burch R.M., The pharmacology of bradykinin receptors. In: Burch R.M. (ed.) Bradykinin Antagonists. Basic and Clinical Research. Marcel Dekker Inc., NY-Basel- Hong Kong 1991, pp. 1-31.
• 3. Marceau F., Immunopharmacology, 30, 1 (1995).
• 4. Perkins M.N., Cambell E. and Dray A., Pain, 53, 191 (1993).
• 5. Reissman S., Schwuchow C., Seyfarth L., Pineda de Castro L.F., Liebemann C., Paegelow I., Werner H. and Stewart J.M., J. Med. Chem., 39, 929 (1996).
• 6. Vitoux B., Aubry A., Cung M.T. and Marrard M., Int. J. Pept. Protein Res., 27, 617 (1986).
• 7. Kyle D.J., Hicks R.P., Blake P.R. and Klimanowski U.J., Conformational properties of bradykinin and bradykinin antagonists. In: Burch R.M. (ed.) Bradykinin Antagonists. Basic and Clinical Research. Marcel Dekker Inc., NY-Basel-Hong Kong 1991, pp. 131.
• 8. Schächter L.R., Uchida Y., Longridge D.J., Łabędź T., Whalley E.T., Vavrek R.J. and Stewart J.M., Br. J. Pharmacol., 92, 851(1987).
• 9. Prahl A., Wierzba T., Winklewski P., Wszędybył M., Cherek M., Juzwa W. and Lammek B., Collect. Czech. Chem. Commun., 62, 1940 (1997).
• 10. Wang S.S., J. Am. Chem. Soc., 95, 1328 (1973).
• 11. Manning M. and Sawyer W.H., Development of selective agonists and antagonists of vasopressin and oxytocin. In: Schrier R.W. (ed.) Vasopressin. Raven Press, NY 1985, pp. 131-144.
• 12. Tallarida R.J. and Murray R.B., Manual of Pharmacologic Calculations, Springer Verlag, Berlin-Heidelberg-NY 1987.
• 13. Urban J., VaisarT., Shen R. and Lee M.S., Int. J. Pept. Protein Res., 47, 182 (1996).
• 14. Lammek B., Wang Y.X., Gavras I. and Gavras H., Peptides, 11, 1041 (1990).
• 15. Lammek B., Kazmierkiewicz R., Ito Y. and Gavras H., Polish J. Chem., 67, 1053 (1993).